Charles Schwab Investment Management Inc. Buys 14,159 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Charles Schwab Investment Management Inc. boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.3% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,100,970 shares of the company's stock after acquiring an additional 14,159 shares during the period. Charles Schwab Investment Management Inc. owned about 1.27% of HealthEquity worth $97,293,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC lifted its position in HealthEquity by 24.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock worth $564,000 after acquiring an additional 1,265 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in HealthEquity by 7,983.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock worth $2,179,000 after buying an additional 24,350 shares during the last quarter. GAMMA Investing LLC grew its stake in HealthEquity by 25.9% during the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock worth $139,000 after buying an additional 323 shares during the last quarter. Wells Fargo & Company MN grew its stake in shares of HealthEquity by 4.7% during the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock valued at $11,988,000 after purchasing an additional 5,594 shares during the last quarter. Finally, WCM Investment Management LLC bought a new stake in shares of HealthEquity during the first quarter valued at approximately $20,230,000. Institutional investors own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In related news, Director Jon Kessler sold 97,767 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.05, for a total value of $10,954,792.35. Following the completion of the transaction, the director directly owned 75,000 shares of the company's stock, valued at $8,403,750. This represents a 56.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 291,744 shares of company stock worth $32,705,007 over the last quarter. 1.50% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

HQY has been the topic of several analyst reports. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. Bank of America lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Raymond James Financial reaffirmed a "strong-buy" rating and set a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Royal Bank Of Canada boosted their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $118.55.

HealthEquity Trading Up 2.8%

Shares of NASDAQ HQY traded up $2.46 during mid-day trading on Friday, reaching $89.89. 894,425 shares of the company's stock were exchanged, compared to its average volume of 838,496. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The firm has a market capitalization of $7.77 billion, a price-to-earnings ratio of 65.61, a PEG ratio of 1.39 and a beta of 0.54. The company's 50-day moving average is $98.42 and its 200-day moving average is $97.27. HealthEquity, Inc. has a 52-week low of $72.79 and a 52-week high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same period last year, the business posted $0.80 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.